首页> 美国卫生研究院文献>Nursing Research and Practice >Epigenetics in Critical Illness: A New Frontier
【2h】

Epigenetics in Critical Illness: A New Frontier

机译:危疾中的表观遗传学:新领域

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epigenetics is the study of alterations in the function of genes that do not involve changes in the DNA sequence. Within the critical care literature, it is a relatively new and exciting avenue of research in describing pathology, clinical course, and developing targeted therapies to improve outcomes. In this paper, we highlight current research relative to critical care that is focused within the major epigenetic mechanisms of DNA methylation, histone modification, microRNA regulation, and composite epigenetic scoring. Within this emerging body of research it is quite clear that the novel therapies of the future will require clinicians to understand and navigate an even more complex and multivariate relationship between genetic, epigenetic, and biochemical mechanisms in conjunction with clinical presentation and course in order to significantly improve outcomes within the acute and critically ill population.
机译:表观遗传学是对不涉及DNA序列变化的基因功能变化的研究。在重症监护文献中,它是描述病理学,临床过程以及开发靶向疗法以改善预后的相对新颖且令人兴奋的研究途径。在本文中,我们重点介绍了与重症监护有关的最新研究,这些研究集中在DNA甲基化,组蛋白修饰,microRNA调控和复合表观遗传评分的主要表观遗传机制内。在这一新兴的研究领域中,很明显,未来的新疗法将需要临床医生理解并导航遗传,表观遗传和生化机制与临床表现和病程之间更复杂,多变量的关系,从而显着地改善急性和重症患者的结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号